Zobrazeno 1 - 10
of 14
pro vyhledávání: '"William H. Yutzy"'
Autor:
Yiping Zhang, Mirit I. Aladjem, Jiuping Ji, Akira Yuno, Haobin Chen, Lan Tran, Susan E. Bates, Sunmin Lee, James H. Doroshow, Robert J. Kinders, Min-Jung Lee, Seth M. Steinberg, Yves Pommier, Christine Alewine, Anish Thomas, Christophe E. Redon, Linda Sciuto, Raffit Hassan, Eva Szabo, Emerson Padiernos, William H. Yutzy, Jane B. Trepel, Udayan Guha, Arun Rajan
Publikováno v:
Journal of Clinical Oncology. 36:1594-1602
Purpose Our preclinical work identified depletion of ATR as a top candidate for topoisomerase 1 (TOP1) inhibitor synthetic lethality and showed that ATR inhibition sensitizes tumors to TOP1 inhibitors. We hypothesized that a combination of selective
Autor:
Jiuping J. Ji, Alice P. Chen, Brad A. Gouker, Ralph E. Parchment, Shivaani Kummar, James H. Doroshow, Kristina M. Bigelow, Robert J. Kinders, Katherine V. Ferry-Galow, Scott M. Lawrence, Deborah Wilsker, Donna Butcher, Thomas D. Pfister, William H. Yutzy, Hala R. Makhlouf, Allison M. Marrero
Publikováno v:
Seminars in Oncology. 43:484-491
Robust pharmacodynamic assay results are valuable for informing go/no-go decisions about continued development of new anti-cancer agents and for identifying combinations of targeted agents, but often pharmacodynamic results are too incomplete or vari
Autor:
Joseph E. Tomaszewski, Martin Gutierrez, Thomas D. Pfister, Ralph E. Parchment, Robert J. Kinders, Julianne L. Holleran, Yves Pommier, Julie L. Eiseman, Larry Rubinstein, James H. Doroshow, Joseph M. Covey, Jan H. Beumer, Shivaani Kummar, Jiuping Ji, Christophe E. Redon, Yiping Zhang, William H. Yutzy, Jerry M. Collins, Alice P. Chen, Deborah Allen, Lihua Wang, William M. Bonner
Publikováno v:
Cancer Chemotherapy and Pharmacology. 78:73-81
Indenoisoquinolines are non-camptothecin topoisomerase I (TopI) inhibitors that overcome the limitations of camptothecins: chemical instability and camptothecin resistance. Two dosing schedules of the novel indenoisoquinoline, indotecan (LMP400), wer
Publikováno v:
Cancer Research. 66:6807-6815
An elevated number of Gr-1+CD11b+ myeloid cells has been described in mice bearing transplantable tumors, and has been associated with immune suppression. We examined the role of such myeloid suppressor cells in mice bearing the spontaneously transfo
Autor:
Brigitte M. Ronnett, Tzyy Choou Wu, Andrea Elko, Patti E. Gravitt, Steven Piantadosi, Chien Fu Hung, Shiwen Peng, Richard W. Daniel, Barbara Wilgus, Cornelia L. Trimble, Keerti V. Shah, Drew M. Pardoll, Richard B.S. Roden, Ellen S. Pizer, William H. Yutzy
Publikováno v:
Clinical Cancer Research. 11:4717-4723
Purpose: Persistent infection with oncogenic human papillomaviruses (HPV) plays a central etiologic role in the development of squamous carcinomas of the cervix and their precursor lesions, cervical intraepithelial neoplasias (CIN). We carried out a
Autor:
Rongcun Yang, Satoshi Uematsu, R. Lee Blosser, Michael Delannoy, Shizuo Akira, Francisco Martinez Murillo, Kiyoshi Takeda, Raphael P. Viscidi, Richard B.S. Roden, William H. Yutzy
Publikováno v:
The Journal of Immunology. 174:7912-7919
Vaccination with human papillomavirus type 16 (HPV16) L1 virus-like particles (VLP) induces both high titer neutralizing IgG and protective immunity. Because protection from experimental infection by papillomavirus is mediated by neutralizing IgG, we
Autor:
Kiyoshi Takeda, Richard B.S. Roden, Ken Yu Lin, Raphael P. Viscidi, Rongcun Yang, Shizuo Akira, William H. Yutzy, Francisco Martinez Murillo, Satoshi Uematsu
Publikováno v:
The Journal of Immunology. 173:2624-2631
Human papillomavirus type-16 (HPV16) L1 virus-like particles (VLPs) activate dendritic cells (DCs) and induce protective immunity. In this study, we demonstrate, using global gene expression analysis, that HPV16 VLPs produce quite distinct innate res
Autor:
Richard B.S. Roden, Ken Yu Lin, Rongcun Yang, William H. Yutzy, Chien Fu Hung, Patricia M. Day
Publikováno v:
Journal of Virology. 77:3531-3541
Human papillomavirus type 16 (HPV16) is the primary etiologic agent of cervical carcinoma, whereas bovine papillomavirus type 1 (BPV1) causes benign fibropapillomas. However, the capsid proteins, L1 and L2, of these divergent papillomaviruses exhibit
Positively Charged Termini of the L2 Minor Capsid Protein Are Necessary for Papillomavirus Infection
Autor:
William H. Yutzy, Patricia M. Day, Brian K. Bronzo, Douglas R. Lowy, Yanqin Yang, John T. Schiller, Richard B.S. Roden
Publikováno v:
Journal of Virology. 75:10493-10497
Coexpression of bovine papillomavirus L1 with L2 mutants lacking either eight N-terminal or nine C-terminal amino acids that encode positively charged domains resulted in wild-type levels of viral genome encapsidation. Despite wild-type binding to th
Autor:
Rosemary Fallon, Douglas R. Lowy, Richard B.S. Roden, Stephen C. Inglis, John T. Schiller, William H. Yutzy
Publikováno v:
Virology. 270:254-257
Vaccination with virus-like particles (VLP), comprising both L1 and L2 of human papillomavirus (HPV) genital types 6, 16, and 18, induces predominantly type-specific neutralizing antibodies. L2 polypeptide vaccines protect animals against experimenta